Results 161 to 170 of about 3,396,597 (298)
Studies in Synthetic Drug Analysis. VIII—Estimation of Salicylates and Phenol. [PDF]
W. O. Emery
openalex +1 more source
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková+14 more
wiley +1 more source
Background: This study was conducted to assess salt production and iodization practices by artisanal salt producers located at six districts across Greater Accra and Central regions.
Benjamin Osei Tutu+5 more
doaj
Utilization and Determinants of Anticancer Drugs Under China's National Drug Price Negotiation Policy. [PDF]
Tuo B, Zhao H, Hu A, Jiang J.
europepmc +1 more source
Factors Affecting the Diffusion of Drugs from Vehicles to the Skin Surface1
J. B. SHELMIRE
openalex +1 more source
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim+11 more
wiley +1 more source
Exploring QSPR in breast cancer drugs via entire neighborhood indices and regression models. [PDF]
Altassan A+4 more
europepmc +1 more source
Electrometric Assay Methods for Crude Drugs**Scientific Section, A. Ph. A, Cleveland meeting, 1922. [PDF]
W. J. McGill, Paul Ellis Faulkner
openalex +1 more source
Chimeric diphtheria toxin–CCL8 cytotoxic peptide for breast cancer management
DTCCL8 is a recombinant fusion toxin that targets cancer cells expressing chemokine receptors. By combining diphtheria toxin with CCL8, DTCCL8 binds to multiple receptors on tumor cells and induces selective cytotoxicity. This strategy enables receptor‐mediated targeting of cancer and may support the development of chemokine‐guided therapeutics ...
Bernardo Chavez+5 more
wiley +1 more source